Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

38 results about "Chromosome microdeletion" patented technology

Amplification composite for detecting microdeletion of Y-chromosome and detection kit

The invention relates to amplification composite for detecting the microdeletion of Y-chromosome and a detection kit, belonging to the field of biotechnical detection. The amplification composite for detecting the microdeletion of Y-chromosome can be amplified to as many as 30 sites related to the microdeletion detection of the Y-chromosome through one reaction. The detection kit detects the microdeletion of the Y-chromosome through the quantitative fluorescent PCR (Polymerase Chain Reaction) method by using the amplification composite. The microdeletion abnormality of the Y-chromosome is determined according to the existence of an amplification product and the quantity of the amplification product. A large quantity of sites enables the detection result to be more convincible and can provide much more and more detailed information for determining the deletion type, and the quantitative detection of partial deletion and repetition can be realized. The detection kit is easier and more convenient to operate, only one PCR amplification and one sequencer detection reaction are needed to complete the detection of one sample, the whole process needs 4-5 h, and the operation intensity and the detection time are greatly reduced.
Owner:BEIJING MICROREAD GENE TECH

Method for detecting chromosome microdeletion and micro-duplication of human embryo

The invention relates to a method for detecting chromosome microdeletion and micro-duplication of a human embryo. The method comprises the following steps of performing whole genome amplification on cells cultured in vitro, interrupting DNA (deoxyribonucleic acid) molecules, and sequencing DNA fragments to obtain sequencing reads; comparing the sequencing reads with a reference sequence, and positioning the sequencing reads on the reference sequence; screening non-repeated areas of the reference sequence, and reserving the non-repeated areas; establishing a matrix of read number in windows through normal samples, analyzing the data of the normal samples, performing statistics on the read number of all the windows in the non-repeated areas, and establishing a probability matrix of the read number and chromosome enpeoids; calculating the copy number, i.e., the A / B / C state, of loci; selecting m continuous loci, i.e., the A state, as micro-duplication loci, and selecting m continuous loci, i.e., the C state, as microdeletion loci; contrasting the micro-duplication loci and the microdeletion loci with the existing CNV (copy number variation) and disease database, performing basic gene annotation and gene function analysis which relates to deletion parts, and annotating with a microdeletion syndrome disease type.
Owner:BEIJING ZHONGYI KANGWEI MEDICAL INSTR

Molecular combination probe for diagnosing and screening chromosome microdeletion syndrome

The invention belongs to the technical field of biology, and particularly relates to a molecular combination probe for diagnosing and screening chromosome microdeletion syndrome. The molecular combination probe is used for selecting the key gene of the Williams syndrome, the 22q11 microdeletion syndrome, the Prader-Willi syndrome, the Angelman syndrome, the 15q13.3 microdeletion syndrome and the Rett syndrome, or the gene within a critical area, or the gens arranged at two ends within a duplication / deletion fragment, selecting the sequence which meets a corresponding condition as a probe sequence according to the sequence of the gene, and adding a general primer sequence and adding a phosphorylation mark to the 5'end of a probe left-half sequence and the 3'end of a right-half probe to prepare the combination probe for the multiple continuous probe amplification technology. According to the combination probe provided by the invention, the defects of the fluorescent quantitative PCR (polymerase chain reaction) can be overcome, a plurality of sequences can be analyzed for once, and the molecular combination probe is higher in resolution ratio, sensitivity and repeatability. The probe can be used for the clinical molecular diagnosing and screening of the six-chromosome microdeletion syndrome.
Owner:FUDAN UNIV

Novel chromosome microdeletion/microduplication syndrome detection system and kit

The invention discloses a novel chromosome microdeletion / microduplication syndrome detection system which mainly comprises 643 pairs of probes, multiplex PCR (polymerase chain reaction) amplification primers and correlation detection reaction reagents. The detection process comprises the following steps: hybridizing a probe set with target nucleic acid in the sample; connecting the hybridized probe; amplifying the connecting probe; and detecting the amplification product to determine the existence or quantity of the target nucleic acid in the sample. The platform can implement systematic screening and detection on 24 chromosome aneuploids, 24 chromosome telomere abnormities, more than 70 chromosome microdeletion / microduplication syndromes and multiple monogenic disease mutation hot spots at one time by using the optimized probe set and reaction system. Compared with the existing like detection techniques (such as MLPA and the like), the detection system covers nearly all definite pathogenic regions with abnormal number of copies in the DECIPHER database, has the advantages of wide detection range, high detection precision and low cost, and is simple to operate.
Owner:SUZHOU MUNICIPAL HOSPITAL +1

Y chromosome microdeletion multiple real-time fluorescence PCR detection kit, amplimer pairs and probes

InactiveCN105018589AQuick checkComprehensive Y chromosome microdeletion informationMicrobiological testing/measurementDNA/RNA fragmentationY chromosome microdeletionFluorescence
The invention relates to a biomolecule diagnostic reagent and discloses a Y chromosome microdeletion multiple real-time fluorescence PCR detection kit. The Y chromosome microdeletion multiple real-time fluorescence PCR detection kit comprises amplimer pairs and fluorescent probes for detecting SY84, SY86, SY127, SY134, SY254, SY255, SY157, SY242, SY1191 and SY1291, and further comprises amplimer pairs and fluorescent probes for detecting sites including at least one of SY82, SY88, SY1064 and SY1065, at least one of SY105, SY121, SY143 and SY153, SY160 and at least one of SY145 and SY152 for detecting AZFd area deletion. The Y chromosome microdeletion multiple real-time fluorescence PCR detection kit can detect 21 STS sites at most, the deletion coverage rate is larger than 99 percent, a multiple real-time fluorescence quantitative PCR technological platform is adopted, Y chromosome microdelection sites can be quickly detected in a high-throughput mode, whether the AZF a, b, c and d areas are deleted completely or partially is distinguished, and more comprehensive Y chromosome microdeletion information is obtained.
Owner:SHANGHAI HENGJIAN BIOTECH CO LTD

Kit for non-invasive prenatal detection of 12 chromosome microdeletion micro-duplex syndromes and special probe set of kit

The invention discloses a kit for non-invasive prenatal detection of 12 chromosome microdeletion micro-duplex syndromes and a special probe set of the kit. The probe set comprises 600 specific probes.Each specific probe sequentially comprises a DNA fragment 1, a DNA fragment 2 and a DNA fragment 3 from the 5' terminal to the 3' terminal. The nucleotide sequences of the DNA fragments 2 of the 600specific probes are sequentially shown from the 16th position to the 93rd position at the 5' terminal of a sequence 1 of a sequence table to the 16th position to the 93rd position at the 5' terminal of a sequence 600 of the sequence table. Experiments prove that the kit can be used for detecting whether a to-be-detected fetus suffers from the 12 chromosome microdeletion micro-duplex syndromes or not, and detection results are completely consistent with detection results of clinical SNP Aarray. The kit has important application value.
Owner:北京迈基诺基因科技股份有限公司

Product for detecting microdeletion of chromosome 16p11.2

The invention discloses a method for detecting microdeletion of 0.6Mb within the area of 29.5-30.1 Mb in a chromosome 16p11.2.According to the detection principle of the method, a small probability event of a genotype homozygous specific product of multiple SNP sites is utilized for judging whether chromosome microdeletion exists or not.The invention also discloses a product for detecting microdeletion of 0.6Mb within the area of 29.5-30.1 Mb in the chromosome 16p11.2.Meanwhile, the product can detect whether an object suffers from congenital scoliosis or not.The detection method and product have a wide clinical application prospect.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI

Primer combination and kit used for detecting Y chromosome microdeletion

ActiveCN106591442AIdentify microdeletionsImprove economyMicrobiological testing/measurementDNA preparationY chromosome microdeletionElectrophoresis
The invention relates to a primer combination and kit for chromosome microdeletion. By the use of a multiple PCR combined with agarose gel electrophoresis technology, seven STS loci closely associated with the Y chromosome microdeletion are detected to judge the microdeletion conditioof a Y chromosome. Seven STS loci with high specificity and sensitivity (sY84, sY86, sY127, sY134, sY254, sY255 and sY160) are chosen as detection loci, at the same time two loci ZFX / Y and SRY are utilized as quality control loci, a primer is designed aiming at each locus respectively, and products of the nine loci after multiplex amplification are directly put on the agarose gel to be conducted electrophoresis detection. By the use of the primer combination and detection system, the Y chromosome microdeletion can be detected only needing single tube amplification reaction.
Owner:北京圣谷智汇医学检验所有限公司

Primer composition for detecting Y chromosome microdeletion and sex chromosome number and application

ActiveCN111471760AIncreased Amplification ConsistencySolving Amplification Consistency IssuesMicrobiological testing/measurementDNA/RNA fragmentationY chromosome microdeletionA-DNA
The invention relates to the field of molecular biology diagnosis, in particular to a primer composition for detecting Y chromosome microdeletion and the sex chromosome number and an application. A Ychromosome AZF region sequence marker site and a sex chromosome number detection site can be simultaneously amplified by utilizing special primer design in a tube of PCR reaction solution; a male sexdetermination gene (SRY) is used as a sex abnormality control and a human X / Y linked zinc finger protein gene (ZFX / Y) is used as an internal control; PCR products are analyzed through capillary electrophoresis; and whether an AZF region of Y chromosome is deleted or not and whether the sex chromosome number is abnormal or not are interpreted by comparing the PCR products with different fragment sizes. A result can be obtained within 3 hours from a DNA sample, the Y chromosome microdeletion and the Klinefelter syndrome can be detected at the same time only through one PCR experiment, the detection technical process is simple, and standardization is easy to achieve.
Owner:XIAMEN BIOFAST BIOTECHNOLOGY CO LTD

Composition and product for detecting Y chromosome microdeletion, application of composition and method

The invention relates to the field of molecular biology, and provides composition for detecting Y chromosome microdeletion. The composition comprises primers and probes with sequences as shown in SEQID NO: 1 to SEQ ID NO: 24. The invention also provides a product comprising the composition and a method using the composition. The composition has the characteristics of simple operation, short time,less pollution, accurate result and the like.
Owner:SHANDONG SHANDA HOSPITAL FOR REPRODIVE MEDICINE

Method of surface plasmon resonance (SPR) to detect genomic disorders for postnatal diagnosis

The present invention discloses using SPR technology to postnatally detect specific DNA loss or gain related to some genomic disorders. An efficient formula to make a mixed SAM that can greatly enhance the immobilization ability of the metal surface in SPR based techniques, which is good for the immobilization of DNA markers used for the identification of subtelomere imbalances and chromosome microdeletion syndromes is also disclosed.
Owner:CMED TECH

Amplification composition for Y chromosome microdeletion detection and kit thereof

The invention discloses an amplification composition for Y chromosome microdeletion detection and a kit thereof. By using primers for amplifying 6 STS sites (AZFa: sY84, sY86; AZFb: sY127, sY134; AZFc: sY254, sY255) and 2 control sites (ZFX / ZFY, SRY), and the six STS sites closely related to the Y chromosome microdeletion are detected by a multiplex PCR combined agarose gel electrophoresis technology to determine the Y chromosome microdeletion. With the amplification composition of the present invention, six STS sites can be simultaneously detected by only two tube amplification reactions.
Owner:BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD

Probe combination and kit for detecting microdeletion and microrepetition of Y chromosome and application of probe combination and kit

PendingCN114015787AConsistent target specificitySame hybridization conditionMicrobiological testing/measurementDNA/RNA fragmentationY chromosome microdeletionChromosome microdeletion
The invention relates to the field of chromosome variation detection, in particular to a probe combination and a kit for detecting microdeletion and microrepetition of a Y chromosome and application of the probe combination and the kit, and the probe combination comprises specific probes aiming at 25 detection points (6 basic points and 19 extension points) of the Y chromosome. When the probe combination provided by the invention is adopted for detection, only Y chromosome microdeletion and microrepetition, 25 point locations, variation interval range judgment and related gene judgment are needed to be simultaneously detected aiming at DNA to be detected in the same reaction tube, and a qualitative and quantitative method containing 6 basic point locations and 19 expansion point locations is adopted. The technical means can be applied to various specimens such as semen, peripheral blood, tissues and the like, and the sample size is required to be only 20-50ngDNA (Deoxyribose Nucleic Acid); the method is short in detection time, economical, simple and convenient, capable of reducing manual operation errors, suitable for various types of samples, visual and accurate in structure interpretation and easy to popularize.
Owner:王晴雪

A method and device for detecting microdeletion in chromosome sts region

A method and a device for detecting microdeletion in a chromosome sequence tagged site (STS) area. The method comprises: selecting an STS area on chromosome, and designing according to a DNA sequence in the STS area to obtain a corresponding capture probe; hybridizing the capture probe and a multi-sample DNA hybrid library, so as to capture the DNA sequence in the STS area in the multi-sample; sequencing the captured DNA sequence in the STS area in the multi-sample of the corresponding capture probe, and obtaining sequencing data; analyzing the sequencing data through a mathematical statistics method, and obtaining a result regarding microdeletion in the chromosome STS area of each sample according to the analysis conclusion.
Owner:BGI GENOMICS CO LTD

Embryo chromosome microdeletion detection method, device and equipment and storage medium

The invention relates to an embryo chromosome microdeletion detection method, device and equipment and a storage medium. According to the embryo chromosome microdeletion detection method, the genotype of the SNV site in the chromosome microdeletion region of the parent party and the parent party is analyzed, the SNV site capable of being used for typing is found, then the genotype of the SNV site is detected in the embryo to be detected, and the chromosome type of the embryo to be detected is analyzed according to the genotype of the SNV site. According to the detection method, the accuracy of analyzing whether the embryo chromosome is microdeletion or not is high, breakpoint detection does not need to be performed on the embryo, the chromosome type of the embryo can be analyzed only according to the genotype of the SNV site, and the operation is simple.
Owner:SUZHOU BASECARE MEDICAL DEVICE CO LTD

Azoospermia chromosome variation detection kit

The invention belongs to the technical field of biological detection, and discloses an azoospermia chromosome variation detection kit. According to the invention, on the basis of retrospective analysis of detection results of chromosome karyotype and Y chromosome microdeletion of patients suffering from azoospermia and establishment of an azoospermia genetic database in China, a multiplex fluorescent quantitative PCR method is adopted to establish a primer probe and a kit for realizing azoospermia chromosome variation detection at one time, the clinical male infertility reason detection efficiency is improved, the cost is reduced, and the period is shortened; meanwhile, the research specially aims at Chinese populations, the clinical actual requirements of China are better met, and the positive detection rate is increased. The cause of male infertility is determined from the molecular level, so that unnecessary treatment is avoided, and the problem that the clinical mutation deletion rate of male offspring is increased due to the application of ICSC is reduced. In addition, the most advanced drying technology is adopted, the detection sensitivity can be improved, the clinical detection process is simplified, and actual use and popularization are more convenient.
Owner:BEIJING CHAOYANG HOSPITAL CAPITAL MEDICAL UNIV +1

Amplification composite for detecting microdeletion of Y-chromosome and detection kit

The invention relates to amplification composite for detecting the microdeletion of Y-chromosome and a detection kit, belonging to the field of biotechnical detection. The amplification composite for detecting the microdeletion of Y-chromosome can be amplified to as many as 30 sites related to the microdeletion detection of the Y-chromosome through one reaction. The detection kit detects the microdeletion of the Y-chromosome through the quantitative fluorescent PCR (Polymerase Chain Reaction) method by using the amplification composite. The microdeletion abnormality of the Y-chromosome is determined according to the existence of an amplification product and the quantity of the amplification product. A large quantity of sites enables the detection result to be more convincible and can provide much more and more detailed information for determining the deletion type, and the quantitative detection of partial deletion and repetition can be realized. The detection kit is easier and more convenient to operate, only one PCR amplification and one sequencer detection reaction are needed to complete the detection of one sample, the whole process needs 4-5 h, and the operation intensity and the detection time are greatly reduced.
Owner:BEIJING MICROREAD GENE TECH

A composition of primers and probes for detecting y-chromosomal microdeletion, a detection method and a kit for non-diagnostic purposes

The invention belongs to the technical field of biological detection, and discloses a composition of primers and probes for detecting Y chromosome microdeletion, a non-diagnostic detection method and a kit. The sY1324, sY127, sY1192, sY85, sY1233, sY254 loci and the SRY gene in the three regions of AZFa, AZFb and AZFc are selected for simultaneous detection, which can identify different deletion types of the Y chromosome, adding the AZFc region b2 / b3, b1 / b3 and b2 / b4 deletion detection rates. The kit only uses nucleic acid amplification reaction A and nucleic acid amplification reaction B, and the combination of the two reactions can realize the detection, breaking through the limitations of the traditional 6-site detection method, improving the positive detection rate and accuracy, and the low cost of reagents, which promotes Domestic independent research and development products have reached the international leading level. Detection by fluorescent quantitative PCR method has high detection efficiency and sensitivity, is convenient, has low requirements for detection equipment and operators, and is convenient for large-scale promotion. Quality control can be carried out for sample extraction, PCR amplification and manual operation throughout the detection process.
Owner:BEIJING CHAOYANG HOSPITAL CAPITAL MEDICAL UNIV +1

A method for detecting chromosomal microdeletions and microduplications in human embryos

The invention relates to a method for detecting chromosome microdeletion and micro-duplication of a human embryo. The method comprises the following steps of performing whole genome amplification on cells cultured in vitro, interrupting DNA (deoxyribonucleic acid) molecules, and sequencing DNA fragments to obtain sequencing reads; comparing the sequencing reads with a reference sequence, and positioning the sequencing reads on the reference sequence; screening non-repeated areas of the reference sequence, and reserving the non-repeated areas; establishing a matrix of read number in windows through normal samples, analyzing the data of the normal samples, performing statistics on the read number of all the windows in the non-repeated areas, and establishing a probability matrix of the read number and chromosome enpeoids; calculating the copy number, i.e., the A / B / C state, of loci; selecting m continuous loci, i.e., the A state, as micro-duplication loci, and selecting m continuous loci, i.e., the C state, as microdeletion loci; contrasting the micro-duplication loci and the microdeletion loci with the existing CNV (copy number variation) and disease database, performing basic gene annotation and gene function analysis which relates to deletion parts, and annotating with a microdeletion syndrome disease type.
Owner:BEIJING ZHONGYI KANGWEI MEDICAL INSTR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products